Can new HIV drug made in Hong Kong prevent and combat the virus that causes Aids?
A team led by scientists from the University of Hong Kong has developed a new antibody drug that will not only protect people from contracting HIV but also serve as a long-acting treatment for the virus, unlike current medication that must be taken daily.
But there will need to be a further battery of tests before the drug, named “BiIA-SG”, can be part of the global battle against the virus, which causes Aids.
The research team has so far only tested the drug on mice but is now looking to experiment on larger animals such as monkeys, before conducting clinical trials on humans.
Still, Professor Chen Zhiwei, the team leader and director of HKU’s Aids Institute, stressed the scientific discovery had yielded “one of the most potent and effective antibody drugs”.